9999999997-17-004705.txt : 20170322 9999999997-17-004705.hdr.sgml : 20170322 20170322155615 ACCESSION NUMBER: 9999999997-17-004705 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20170322 DATE AS OF CHANGE: 20170322 20170322 20170322 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ACCELERON PHARMA INC CENTRAL INDEX KEY: 0001280600 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 001-36065 FILM NUMBER: 17706688 BUSINESS ADDRESS: STREET 1: 128 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-649-9200 MAIL ADDRESS: STREET 1: 128 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 CT ORDER 1 filename1.pdf begin 644 filename1.pdf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